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Predicting risk of death based on personalised and objective clinical indicators is an 
improvement over intuition and clinical judgment. Risk assessment can benefit clinicians by 
improving prognostic certainty, and truth disclosure helps patients and families by preventing 
futile management. Some argue that consent should be obtained before a patient is given an 
estimate of their prognosis as disclosure of bad news can overburden patients. In this article 
we argue that it is unethical not to use existing person-specific information to guide diagnosis 
and shared decision-making on management in partnership with well-informed patients. 
Disclosure of a poor prognosis should be normalized in personalized medicine, performed 
incrementally and with sensitivity so that it is acceptable to patients, and only occur if 
patients want to know it. However, a requirement of consent for truth disclosure should not 
be mandatory. Despite some level of imprecision, personalized risk estimations can be used 
to tailor management to the patient's informed wishes, and ensure that healthcare providers 
and families are acting ethically in the patient's best interest. 
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Prognostication is a challenging art, and science. Through advanced age, increasing frailty 
and chronic illness, treatment becomes increasing complex and the clinician’s ability to 
prognosticate is tested further. Prognosis does not solely rely on the natural history of a major 
disease but on the interaction with other comorbidities, the choice of treatment and response 
to it, and other patient-specific socio-demographic influences, all of which may impact on the 
accuracy of the prediction. Yet prognostication has become a lost skill: at the end of the 
nineteenth century prognostication took up about ten percent of medical textbooks, but by 
1970 it was hardly addressed. 
1
  As a result, although modern physicians commonly 
encounter situations that require prognostication, they feel “poorly trained to do it, and find 





Personalized medicine has b en broadly defined as “the tailoring of medical treatment to the 
individual characteristics, needs and preferences of a patient during all stages of care, 
including prevention, diagnosis, treatment and follow-up”. 
3
 Data to assist personalized 
decisions tailored to individuals, thus departing from the “one size fits all” paradigm 
4
 is 
valuable as disease trajectories vary, and individuals respond differently to treatment options 
and value different states of health.  The development of prediction tools for all ages, and in 
particular the very old, 
5
 provides information on likely outcomes, including death, and is but 
one essential component of truthful communication. 
 
Delivering a prognosis, especially a bad one, is complex, takes time, and requires sensitive 
communication filled with good judgment, skill, empathy and compassion. Some patients 
may hold beliefs that can distort their understanding or expectations of cure; others may 
choose to know less as disease progresses or ask more about the risk of treatments; and 
families may want to know more about what to expect of the course of illness and the time to 
death. So proficiency in tactful disclosure becomes necessary when dealing with older 
patients suffering complex co-morbidities. 
6
  However, many patients and families may find 
confronting such an explicit prognosis challenging. This is largely because popular culture 
continues to promote the myth that there is an effective treatment for every illness and that 
medical technology, no matter how painful or expensive, should be used at all costs. All 
deaths are, therefore perceived as “failures” of medicine. 
7
  Even today,  some medical and 
nursing schools’ curricula do not emphasise sensitive communication training; and some 
health systems are yet to abandon paternalistic attitudes and therefore are still not 
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systematically encouraging patient autonomy, either through voluntary or mandatory 
approaches. The solution is not to avoid the difficult discussion using unpredictability of 
disease progression as an excuse and thus deny the patient their right to know, but to improve 
expertise in providing a personalized prognosis in order to empower patients to take control 
of their immediate or future care.  
 
Although giving information on the progression and recurrence of illness, along with advice 
and shared decision-making, is now a routine- and accepted- part of cancer care,   there is  
concern that unwanted information may overburden patients and families and take away 
hope,  so that in geriatric and critical care populations providing a prognosis is sometimes 
viewed  as overriding patient autonomy and potentially causing harm. 
8
 It has therefore been 
suggested by others that consent for disclosure should be obtained before a patient is told 
their risk of death. Yet, in routine practice with non-terminal patients anyone who consults a 
physician implies consent to being given a professional opinion on their probable diagnosis, 
prognosis and treatment. While some prognostically important tests require explicit informed 
consent, as for HIV testing, neither evidence nor law provide clear guidance on the need for 
or benefit of detailed, written consent for discussions about other diagnoses. At present, the 
judgment about whether or not to disclose prognosis is often left up to the physician. The 
appropriateness of disclosing prognosis to elderly patients who have their lost decision-
making capacity and do not have a surrogate decision-maker is particularly concerning, 
because such patients would not be able to make subsequent decision.  It is said that “consent 
was developed for research ethics, not for clinical care.
9
 While consent to perform invasive 
procedures is the norm and a service requirement, we believe consent to communicate 
prognosis is both a moral obligation and an ethical requirement that fosters patient autonomy. 
 
Although it is important to respect the right of patients not to know their prognosis, telling a 
patient their risk of death can help them wisely direct their subsequent treatment. There are 
many benefits provided by an accurate estimation of a patient’s time to death and their 
clinical course prior to death: for patients and their relatives being clearer that cure is unlikely 
and burdensome interventions can be harmful, provides opportunities to discuss preferences, 
consider comfort and palliative care if indicated, and coordinate services accordingly. 
10
 In 
fact, increased certainty regarding disease trajectory can be liberating for some, as it puts a 
timeframe to the end of suffering, assists in the planning of their final days with good quality, 
and helps them to embrace the inevitable: death from old age, frailty, chronic illness, and 
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  concepts that modern society often attempts to deny. For clinicians, an 
accurate prognosis  can help avoid futile and potentially harmful therapies, assist end-of-life 
care that best responds to patient and family values and preferences, and ensure better 
stewardship of scarce health system resources. 
12
 But delivery of patient-centred care would 
of course include adherence to the patient’s disclosure preferences. 
 
One of the pillars of personalized medicine is the sharing of prognostic data between patient 
and clinician so that patients engage in a proactive and dynamic decision-making 
partnership.
13
 Not only is outcome estimation a necessary step in routine practice, many 
clinicians find it a rewarding experience, as patients often welcome their guidance at a 
seminal time in their lives. Factors such as education, age, disease type, availability of social 
or medical support, religion or cultural background, family dynamics and the way in which 
prognosis is delivered impact on people’s openness to the news of an impending death.  
Certainly, no one wants to receive or digest bad news, and there will always be those who 
prefer little or no disclosure of poor prognosis in terminal illness; this is their right. 
Nevertheless, we believe it is unethical and unjust not to formulate an explicit person-specific 
prognosis when the information and technology that can do so are available. Withholding that 
information undermines justice and autonomy, except if the concept of autonomy extends to 
the right to not know.
14
 The estimated risk of death and the benefits of less aggressive 
interventions should be disclosed to all patients, unless they choose otherwise, and it is not in 
the patient’s best interest to withhold information or give false hope with overoptimistic 
outcome predictions, as this may lead to loss of patient trust.   In the case of chronic or 
progressive disease, ideally, patients and healthcare professionals will have the opportunity to 
revisit disclosure preferences, as with other goals of care, over time, as these may change. 
The timing of re-discussion will need to be individualised to the patient. 
 
A more accurate, personalized prognosis also allows patients to more confidently formulate 
advanced care directives, reflecting their values and goals. The absence of health care 
directives, based on accurately estimated likely outcomes, hampers wise decision-making and 
often leads to regret when clinicians or families have to make decisions on behalf of patient 
without knowing their wishes. Without them clinicians can also experience job dissatisfaction 
and moral distress if they feel urged to comply with family requests to administer futile 
treatment. While patients may change their mind in either direction about treatment 
preferences as their age increases, their disease progresses and their ability to partake in 
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decision-making varies ,  accurate prediction of their individual risks may make this change 
of mind less likely. An individualised prognosis that is based on the unique health 
determinants of an individual’s profile will improve patient’s understanding of their own 
disease, and clarify their own goals of care. Since all involved in delivering care will have a 
realistic perception of the patient’s life expectancy, prevention of unnecessary, potentially 
harmful treatments would be prevented, distributive justice 
15
 may be achieved,  and the 
family’s anticipatory grief may also be reduced. 
 
In summary, despite the ever-present uncertainty in healthcare, personalised risk prediction 
near the end of life is possible, and a professional responsibility. Prognostic disclosure should 
be normalised and offered regulatory support without the barriers of formal consent 
procedures.  Timely communication of a poor prognosis and risk of death needs a sensitive, 
incremental approach and should be in a format that patients and families find acceptable and 
can understand. Precise predictions of the future are never possible, but well validated 
actuarial science and recent advances in information technology, genetics and other areas of 
medical biology now make it possible to formulate much improved estimates of the likely 
outcomes for individual patients.   Even if some level of imprecision remains, personalized 
risk estimations should inform care pathways, as they make it possible to tailor management 
to the patient’s informed wishes, and ensure that physicians, family and other healthcare 
providers are acting in the patient’s best interest. 
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